某院2013年—2015年癌症患者三阶梯镇痛药物的临床用药分析  

Analysis of Clinical Medication of Tri-steps Analgesic Drugs in Patients with Cancer during 2013 and 2015

作　　者：易蕾[1] 杨晓艳[1] 

机构地区：[1]武汉科技大学附属天佑医院,武汉430064

出　　处：《抗感染药学》2016年第5期991-995,共5页Anti-infection Pharmacy

摘　　要：目的:分析医院2013年—2015年间癌症患者三阶梯镇痛药物的临床使用情况,为临床合理使用镇痛药物提供参考。方法:提取医院HIS系统中2013年—2015年癌症患者三阶梯镇痛药物的临床使用相关数据,分析7种癌症患者药品使用金额、用药频率(DDDs)和日均费用(DDC)。结果:7种癌症患者的镇痛药物以第三阶梯用药为主,其使用金额和DDDs为最高,DDC用前三位分别是地佐辛注射液、羟考酮缓释片和芬太尼透皮贴。结论:医院癌症患者三阶梯镇痛药物的临床使用属基本合理,但仍需要进一步加强监管。Objective： To analyze the status and developing trend of clinical medication of tri-steps analgesic drug in patients with cancer during 2013 and 2015, and to provide a reference for rational use of analgesic drugs. Methods： The data of tri-steps analgesic drug in patients with cancer in a certain hospital during 2013 and 2015 were collected from the Hospital Information System（HIS）, and the following indicators, including consumption sum, DDDs and DDC of seven kinds of cancer patients were analyzed statistically. Results： For the use of analgesic drugs seven kinds of can- cer patients were given priority to with the third ladder, the average daily cost top three drugs are dezocine injection, oxycodone sustained release tablets and fentanyl transdermal patches respectively. Conclusion： The use of clinical med- ication of tri-steps analgesic drug in patients with cancer in a certain hospital is basically rational, but the supervision and management of rational use should be further strengthend.

关 键 词：镇痛药物 三阶梯 合理用药 癌症 用药频率 日均费用 

分 类 号：R969.3[医药卫生—药理学]